KIDNEY DISEASE, CHRONIC

This study tests whether semaglutide, a diabetes drug, is safe and tolerable for people with type 2 diabetes who are on dialysis. About 100 participants will either receive weekly semaglutide injections or standard care for 26 weeks. The goal is to see if patients can stick with …

This study tests whether adding BI 690517 (Vicadrostat) to empagliflozin can slow kidney disease and prevent heart failure hospitalizations or cardiovascular death in people with chronic kidney disease. About 11,000 adults with or without type 2 diabetes will take either BI 69051…

This study tests a new treatment called AdiaVita, made from umbilical cord stem cells, for adults with chronic kidney disease. About 100 people aged 18 to 80 with moderate kidney problems will receive monthly infusions and a daily skin spray for three months. The goal is to see i…

This study tests an oral testosterone pill called JATENZO in 20 men who have both low testosterone and chronic kidney disease. The goal is to see if the pill can raise testosterone levels and improve red blood cell counts, muscle strength, lean body mass, and sexual function. Par…

This study tests whether a special egg white protein pudding can help people with kidney failure who are on dialysis. Participants will eat one pudding after each dialysis session, three times a week for 12 weeks. The researchers want to see if this is practical and if it improve…

This study tests whether a ketoanalogue supplement (Ketosteril) can prevent muscle loss in 100 adults with stage 4 or 5 chronic kidney disease who are on a moderately low-protein diet. Participants take the supplement daily for a period, and researchers measure changes in muscle …

This study tests whether checking a patient's genes before a kidney transplant can help doctors choose the best starting dose of the anti-rejection drug tacrolimus. About 114 adults on the transplant waiting list will be randomly assigned to either standard dosing or a dose based…

This study looks at how genes influence the risk of kidney disease. Anyone 18 or older living in the US can join, even without kidney disease. Participation is online: you fill out health surveys and mail in a saliva sample. You may get free genetic ancestry information in return…

This study is tracking 200 kidney transplant patients in Scotland to see if certain biomarkers can help predict transplant rejection. Researchers will compare biomarker levels with standard biopsy results. The goal is to find a simpler, less invasive way to monitor transplant hea…